Study Title | AALL1631: International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones |
---|---|
Protocol ID | AALL1631 |
Disease (Sub Disease) | Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia Mixed Phenotype Acute Leukemia T Acute Lymphoblastic Leukemia |
Diagnosis Stage | New diagnosis |
Location | NSW / QLD / WA |
Sponsor | Children's Oncology Group |
Collaborators | National Cancer Institute (NCI)/ EsPhALL network I-BFM Study Group |
Links | https://clinicaltrials.gov/ct2/show/NCT03007147 |
Trial Status | Open |
Trial Open Date | 19/04/2018 |
Sites | The Children's Hospital at Westmead / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Christchurch Hospital / Starship Hospital/ John Hunter Children's Hospital |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | 1 year to 21 years at diagnosis |
International registry ID's | NCT03007147 |